
Pfizer sold $7.8B in COVID vaccines in 2Q, predicts more Delta-driven demand
NY Post
Pfizer sold a staggering $7.8 billion worth of coronavirus jabs during the second quarter — and predicted its profits will continue to explode as the Delta variant spurs fresh demand for booster shots.
The New York pharma giant — which said it is planning to submit a COVID booster shot for approval as soon as next week — expects to make a whopping $33.5 billion from selling 2.1 billion coronavirus vaccines this year, chief financial officer Frank D’Amelio told investors on Wednesday. That’s a nearly 30 percent increase from the company’s previous projections — and makes the two-dose vaccine, which was developed jointly with Germany’s BioNTech, among the most profitable drugs in history.More Related News

Gas prices reach highest level since October 2023 as oil holds above $100 per barrel; US stocks jump
Brent crude oil held above $100 per barrel on Monday, pushing national average gasoline prices to their highest level since October 2023 as President Trump urged allies to help protect oil tankers from Iranian attacks in the key Strait of Hormuz.












